Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

• Research unit: INNOSUISSE
• Project number: 19310.1 PFLS-LS

Short description (German)

Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Short description (English)

Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Abstract (German)

To develop novel peptide drug conjugates that target a newly identified cancer marker overexpressed in multiple cancers. The project aims to create peptide drug conjugates for treating acute myeloid leukemia and obtain at least one drug candidate ready for further development. This will enable Phi Pharma to secure additional financing to prepare for the first clinical trial, and eventually enter into a significant collaboration with a major pharmaceutical company.

Abstract (English)